Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I8HL
|
||||
Former ID |
DNC011545
|
||||
Drug Name |
(D)Arg-Arg-Pro-Hyp-Gly-Thi-Ser-(D)Tic-Aoc-Arg
|
||||
Indication | Discovery agent | Investigative | [529475] | ||
Structure |
Download2D MOL |
||||
Formula |
C58H87N19O13S
|
||||
Canonical SMILES |
C1CC2CC(N(C2C1)C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(<br />CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN<br />=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O
|
||||
InChI |
1S/C58H87N19O13S/c59-36(13-4-18-66-56(60)61)47(81)71-37(14-5-19-67-57(62)63)51(85)74-21-7-17-42(74)53(87)76-29-34(79)25-43(76)49(83)69-27-46(80)70-39(26-35-12-8-22-91-35)48(82)73-40(30-78)52(86)75-28-33-10-2-1-9-31(33)23-45(75)54(88)77-41-16-3-11-32(41)24-44(77)50(84)72-38(55(89)90)15-6-20-68-58(64)65/h1-2,8-10,12,22,32,34,36-45,78-79H,3-7,11,13-21,23-30,59H2,(H,69,83)(H,70,80)(H,71,81)(H,72,84)(H,73,82)(H,89,90)(H4,60,61,66)(H4,62,63,67)(H4,64,65,68)/t32?,34?,36-,37-,38?,39?,40-,41?,42-,43-,44?,45?/m1/s1
|
||||
InChIKey |
TZXGWOFUQYJXKR-OSXXQWSASA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | B2 bradykinin receptor | Target Info | Inhibitor | [529475] | |
KEGG Pathway | Calcium signaling pathway | ||||
cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Complement and coagulation cascades | |||||
Inflammatory mediator regulation of TRP channels | |||||
Regulation of actin cytoskeleton | |||||
Endocrine and other factor-regulated calcium reabsorption | |||||
Chagas disease (American trypanosomiasis) | |||||
Pathways in cancer | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Direct p53 effectors | ||||
Validated transcriptional targets of deltaNp63 isoforms | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.